drugset
drugset / Trial / NCT05467696

Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers

NCT05467696 ↗

Phase 1 Completed 16 enrolled Concert Pharmaceuticals
RandomizedCrossoverOpen-labelOther

Summary

This is an open-label, single-dose, two period crossover study to evaluate the effect of food on the bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers

Timeline

Start
2022-06-14
Primary completion
2022-06-26
Completion
2022-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject CTP-543 Unknown 12 mg —

Indications

No indication recorded.